Published on
January 4, 2018
- 12:00 GMT
TearLab Submits 510(k) for U.S. FDA Clearance of TearLab Discovery™ Platform
SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX:TLB) (“TearLab” or the “Company”) today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for the potential clearance of …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
